Adaptive Biotechnologies (ADPT) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $28.17 -0.7%
Revenue Growth %: -23.8%
Financial Fact:
Total operating expenses: 36.9M
Today's EPS Names:
PFBX, GOVB, VABK, More
Revenue Growth %: -23.8%
Financial Fact:
Total operating expenses: 36.9M
Today's EPS Names:
PFBX, GOVB, VABK, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q2 EPS of ($0.35), $0.07 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $38.5 million versus the consensus estimate of $31.26 million.
GUIDANCE:
Adaptive Biotechnologies sees FY2021 revenue of $148-155 million, versus the consensus of $150.2 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SPS Commerce (SPSC) Tops Q3 EPS by 16c; Offers Guidance
- AptarGroup (ATR) Tops Q3 EPS by 5c
- Exponent, Inc. (EXPO) Tops Q3 EPS by 4c; offers outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
